SCHEMBL4091705

SCHEMBL4091705

CCN(C)C(=O)c1ccc(-c2cnc3nnc(C4(c5ccc6ncccc6c5)CC4)n3n2)cc1N(C)c1ccccn1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.43
CDKL5 O76039 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836056 0.82 MET (0.43) MET
SCHEMBL837714 0.80 MET (0.54) METCDKL5
SCHEMBL838098 0.79 MET (0.49) MET
SCHEMBL14291366 0.78 MET (0.41) MET
SCHEMBL835600 0.77 MET (0.59) METCDKL5
SCHEMBL837534 0.77 MET (0.56) METCDKL5
SCHEMBL836523 0.77 MET (0.51) MET
SCHEMBL837508 0.76 MET (0.54) METCDKL5
SCHEMBL836073 0.76 MET (0.49) MET
SCHEMBL836134 0.76 MET (0.56) METCDKL5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2057164-A1 TRIAZOLOTRIAZINES AS KINASE INHIBITORS Incyte Corporation (US) 2009-05-13 EP disclosed
WO-2008021781-A1 TRIAZOLOTRIAZINES AS KINASE INHIBITORS INCYTE CORPORATION (US) 2008-02-21 WO disclosed